Charlottesville, Virginia – The newly formed Aniridia North America (ANA) announces its first event to strengthen and expand research focused on aniridia and related problems. The 2021 Aniridia North America Symposium: PAX6, Aniridia, and Beyond will bring together top researchers from North America and around the world.
This meeting, like its predecessor, the 2019 John F. Anderson Symposium: PAX6 and Beyond, will provide a forum for the scientific community to present current aniridia research findings and facilitate collaboration on future studies. Sessions will focus on aniridia-related issues including glaucoma, corneal health, and genetics.
By bringing experts from a variety of perspectives in the fields of eye formation, health and disease, we can glean ways to enrich our own findings and those of others. This meeting will provide a unique opportunity for the scientific community to brainstorm and more quickly develop solutions for problems related to aniridia.”Robert Grainger, PhD, ANA Chairperson, Meetings Committee
The leaders of patient advocacy organizations will attend the meeting to represent the needs of people with aniridia. After the meeting, these leaders will share patient-friendly summaries of meeting presentations.
“The 2019 event inspired so much hope. As a result, VFT expanded its research network and uncovered new studies worth funding. We expect similar results from this meeting and are excited to share the findings as we learn more.”Susan Wolfe, Vision for Tomorrow (VFT) and ANA Board member.
The 2021 Aniridia North America Symposium: PAX6, Aniridia, and Beyond and ongoing research education is part of the vision of ANA. It will be held November 5-7 at the University of Virginia in Charlottesville.
This meeting was made possible by generous funding and support from the University of Virginia, Vision for Tomorrow, the University of Georgia, and the International WAGR Syndrome Association.